Results 181 to 190 of about 37,214 (250)

Osteoporosis therapies and coronary risk: insights from vascular calcification biology and sclerostin signaling. [PDF]

Front Endocrinol (Lausanne)
Weng S, Ding C, Shi Y, Zhang H, Zhao W, Zhu J, Peng F, Chai D.   +7 more
europepmc   +1 more source

Denosumab Versus Bisphosphonates in Glucocorticoid-Induced Osteoporosis: A Systematic Review. [PDF]

Cureus
Ahmed AE, Alzaylaee WA, Suhluli AS, Essa SA, Bahkali LM, Hakami AM, Alshamrani RA, Alharbi FR, Alhazmi RH, Khurayzi TH, Almihbash AK.   +10 more
europepmc   +1 more source

Updates in Cystic Fibrosis Bone Disease in Adults. [PDF]

Endocr Pract
Runchey S, Harindhanavudhi T, Wu M, Tangpricha V.   +3 more
europepmc   +1 more source

Initial Denosumab Versus Sequential Bisphosphonate-to-Denosumab for Prevention of Skeletal-Related Events in Breast Cancer with Bone Metastases: A Retrospective, Single-Center Study. [PDF]

Cancers (Basel)
Zhao Y, Yu B, Feng W, Xie Y, Shi Y, Cao J.   +5 more
europepmc   +1 more source

Use of romosozumab for osteoporosis in β-thalassemia major. [PDF]

JBMR Plus
Ng C, Samad N, Trinh A, Milat F, Wong P.
europepmc   +1 more source

The use of denosumab in rare bone diseases in adults: a systematic review from the ECTS Rare Bone Disease Action Group.

J Clin Endocrinol Metab
Bulaicon OO, van Haalen FM, Clunie GPR, Grasemann C, Lems WF, Makras P, Mortier G, Oheim R, Raimann A, Siggelkow H, Tabacco G, van der Wal RJP, de Witte PB, Appelman-Dijkstra NM.   +13 more
europepmc   +1 more source

The effectiveness of bisphosphonates vs denosumab in people with dementia or frailty post hip fracture: a multi-database cohort study. [PDF]

Osteoporos Int
Ilomäki J, Wood SJ, Tan GSQ, Kim SJ, Leung MTY, Sing CW, Cheung CL, Lai EC, Hsieh MH, Ma TT, Lau WCY, Wong ICK, Cameron ID, Bell JS.   +13 more
europepmc   +1 more source

Bisphosphonates in hormone-sensitive metastatic prostate cancer: do they still matter? [PDF]

Ann Med Surg (Lond)
Shakil S, Ijaz M, Shah AK.
europepmc   +1 more source

Comparative efficacy and safety of teriparatide versus bisphosphonates in osteoporosis: a meta-analysis. [PDF]

Front Surg
Jin H, Dong Y, Huang C, Wang D, He Z, Shen L, Ma C, Wang Z, Shi S, Shuai B.   +9 more
europepmc   +1 more source

Identifying the clinical indicator for surgical intervention in medication-related osteonecrosis of the jaw. [PDF]

J Bone Miner Metab
Tadokoro Y, Hasegawa T, Takeda D, Hirota J, Uryu K, Shirai T, Muraki Y, Akashi M.   +7 more
europepmc   +1 more source